id=44). In January 2005, the U.S. Food and Drug Administration licensed a new tetravalent meningococcal conjugate vaccine ([MCV4] Menactra) for use in people 11-55 years of age. MCV4 contains ...

MOBILE, Ala. (WALA) - The Mobile County Health Department has confirmed a case of meningococcal disease -- the first case reported in the county this year. Meningococcal disease can cause ...

The shortage of MCV4 that occurred shortly after routine administration was recommended provides an example of limited supply leading to decreased vaccination rates. [20] This type of vaccine ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.